Megakaryon Corp. operates as an pluripotent stem cells research laboratory. It produce platelets and red blood cells from iPS cell lines, and to develop blood products that do not depend on blood donations. The firm specializes in development of technologies to produce and store induced pluripotent stem cell derived human T cells. Megakaryon was founded by Genjiro Miwa on September 9, 2011 and is headquartered in Kyoto, Japan.

Changchun Weishi Testing Technology Service Co., Ltd., established on 2016-01-15, Business scope includes licensed projects:Inspection and testing service;Quality and safety inspection of agricultural products;Forestry product quality inspection and testing;Class III medical device business;Experimental animal management.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Forest grass seed quality inspection;Metering technical service;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;R&D and application of cell technology;Research and development of bio-based materials technology;Biochemical product technology research and development;Extraction of marine bioactive substances,purification,Synthesis technology research and development;Agricultural Science Research and Experimental Development;Bio-organic fertilizer research and development;Medical Research and Experimental Development;Drug testing equipment sales;Testing machine sales;Pharmaceutical special equipment sales;drawing,Sales of computing and measuring instruments;Sales of electronic measuring instruments;Sales of electrical instruments and meters;Retailing of computer software, hardware and auxiliary equipment;Photovoltaic equipment and components sales;Sales of special instruments and meters for agriculture, forestry, animal husbandry and fishery;Experimental analysis instrument sales;Specialty Chemicals Sales(Free of Hazardous Chemicals);Chemical product sales(No licensed chemical products);Rubber Products Sales;Sales of teaching models and teaching aids;Import and export;Production of Class I Medical Devices;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Educational Consulting Services(Education and training activities that do not include licensing approval);business training(Does not include education and training,Vocational skills training and other licensed training);General Equipment Repair;Special Equipment Repair;electrical equipment repair;Instrument Repair;Import and export agency;Technology Import and Export.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

IncellDx, Inc. detects and monitors life threatening diseases. It offers transformative diagnostic and prognostic clinical patient information based on an innovative technology platform that enables simultaneous cell classification and single cell analysis of proteomic and genomic biomarkers. The company was founded by Bruce K. Patterson and Carol Penfold-Patterson on December 3, 2009 and is headquartered in Menlo Park, CA.

Ligue Nationale Contre Le Cancer is a private company headquartered in France that operates as voluntary health organization.

Guangzhou Kedio Technology Service Co., Ltd., established on 2019-03-04, Business scope includes technical services(Does not include license approval items);Research and development of biodiagnostic reagents and kits(Does not include license approval items);Information Technology Consulting Services;Data Processing and Storage Services;Information system integration service;horticultural crops planting;Planting of other cash crops;Commodity wholesale trade(Except for licensed and approved products);Medical supplies and equipment retail(Does not contain drugs and medical devices);Medical equipment rental service;Medical Equipment Repair;Chinese herbal medicine planting;Food Science and Technology Research Services;computer technology development,Technical Services;Agricultural technology extension service;Research on Network Technology,to develop;Flower Crops Wholesale;flower planting;Natural science research and experimental development;Biotechnology Extension Services;Agricultural Science Research and Experimental Development;Medical Research and Experimental Development;software development;

Wankangyuan (Tianjin) Gene Technology Co., Ltd., established on 2015-01-06, The business scope includes genetic medicine related equipment and electronic products,Technology development of computer hardware and software,transfer,Consulting and Services;Health Information Consultation(Except for medical advice);biotechnology development,Technical Services,technology transfer,technical consulting;Conference Services;Exhibition;Computer System Services;Computer hardware and software and auxiliary equipment,Equipment,Instrumentation,Chemical Products(Hazardous chemicals and precursor drugs are excluded),Wujinjiaodian,Machinery sales;Goods and technology import and export business;Pharmaceutical Technology Development,technical consulting,Technical Services,technology transfer.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Part of Southern Medical University, Zhujiang Hospital of Southern Medical University is a company headquartered in Guangzhou, China, that operates hospital.

Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France.

Stemcentrx, Inc. develops life-changing therapies for cancer patients. It develops proprietary discovery platforms that yield unprecedented insight into the biology of tumors and are being exploited to develop potent new cancer drugs. The firm specializes in designing drugs to target cancer stem cells, which are the cells that cause cancer to spread throughout the body. The company was founded by Brian Christopher Slingerland, Daniel T. Reiner and Scott J. Dylla in 2008 and is headquartered in San Francisco, CA.

Deyun Kangming (Xiamen) Biotechnology Co., Ltd., established on 2017-04-18, Business scope includes general items:Engineering and Technology Research and Experimental Development;Medical Research and Experimental Development;Sales of Class II Medical Devices;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Specialty Chemicals Sales(Free of Hazardous Chemicals);Sales of daily chemical products;Instrument Manufacturing;Instrument sales;Information system integration service;software development;Manufacturing of computer software, hardware and peripheral equipment;Wholesale of computer software, hardware and auxiliary equipment;Retailing of computer software, hardware and auxiliary equipment;Sales of hygiene products and single-use medical products;Conference and Exhibition Services;Sales of Class I Medical Devices;Production of Class I Medical Devices.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).licensed items:Production of Class II Medical Devices;Class III medical device business;Production of Class III Medical Devices.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments).

Encodia provides in-depth information on cellular processes to enable personalized medicine. Our technology reverse translates peptide sequence information into a DNA library. This means scientists can scale their research more easily to accelerate novel approaches to our most challenging diseases. Encodia was established on January 1, 2015 in San Diego, California.

Helio Health is an AI-driven healthcare company focused on commercializing early cancer detection tests from a simple blood draw. The company’s mission is to simplify cancer screening so lives can be saved by detecting cancer earlier. With Helio’s AI-driven technology, both physicians and their patients gain powerful insights from accurate, accessible, and convenient blood tests. Helio’s development program is focused on liver, colon, breast and lung cancer. Helio Health is headquartered in Irvine, CA, with R&D, GMP and CLIA facilities in Irvine, CA and West Lafayette, IN.

Robert Bosch GmbH engages in the development of the engineering and electronics sector. Its business sectors include; mobility solutions, industrial technology, consumer goods, and energy and building technology. The company was founded by Robert Bosch in 1886 and is headquartered in Gerlingen-Schillerhöhe, Germany.

GENE DENOVO provides omics sequencing and bioinformatics analysis services. It is a genome sequencing, medical consultation, and health information management company. For inquiries, email, telephone numbers, and physical addresses are available on their website.

Daegu Gyeongbuk Institute of Science and Technology (DGIST) (In Korean 대구경북과학기술원) is a public science and engineering university located in Daegu Metropolitan City, Republic of Korea. Under a Special Act on Support of Scientists and Engineers for Strengthening National Science and Technology Competitiveness, the Korean government enacted Daegu Gyeongbuk Institute of Science and Technology Act (Act No. 6996) and founded DGIST in 2004 as a research institute. In 2008, the act was amended to extend the role of the institute to both research and education, which eventually enabled a transition from a research institute to a university.

Pfizer Inc. (NYSE: PFE, /ˈfaɪzər/) is an American multinational pharmaceutical corporation headquartered in New York City was founded in 1849, based in New York City and was listed on New York Stock Exchange. It is one of the world's largest pharmaceutical companies. It is listed on the New York Stock Exchange, and its shares have been a component of the Dow Jones Industrial Average since 2004. Pfizer ranked No. 57 on the 2018 Fortune 500 list of the largest United States corporations by total revenue.

Zhejiang Qingyuan Biotechnology Co., Ltd., established on 2016-11-21, Business scope includes medical and biological related technical services;Genetic Testing and Genetic Counseling;Circulating Tumor Cell Detection(Does not include medical services).